Sanofi (TSX:SNY)

Market Cap	162.45B
Revenue (ttm)	75.06B
Net Income (ttm)	14.89B
Shares Out	n/a
EPS (ttm)	12.08
PE Ratio	10.91
Forward PE	10.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	324
Open	22.02
Previous Close	21.54
Day's Range	22.02 - 22.02
52-Week Range	21.08 - 22.57
Beta	n/a
RSI	n/a
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: SNY

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR